StockData
Caribou Biosciences, Inc. logo

Caribou Biosciences, Inc. (CRBU) stock

CRBUNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3074% below fair value
$0.33−0.01 (-4.29%)

Close on Nov 18, 2026Market cap $34.96MP/E –Yield –

Caribou Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Caribou Biosciences's market cap was $41.41M on Nov 11, 2026, against $181.33M a year earlier. Over the last 5 years it ranged from $41.41M to $905.72M, with a median of $239.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$41.41M-72.1%
2025Dec 31, 2025$148.61M+3.2%
2024Dec 31, 2024$143.98M-71.6%
2023Dec 29, 2023$506.71M+32.3%
2022Dec 30, 2022$383.00M-57.7%
2021Dec 31, 2021$905.72M–

More Caribou Biosciences figures

See a number that looks wrong?